trial

Optimizing CBSST With Executive Function Training for Schizophrenia

NCTId NCT06251193
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 49 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2026-02-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
49 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-03-20
Primary completion
2026-02-10
Eligibility
ALL · 60 Years

Interventions & indications

Drugs
E-CBSST

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
Centre for Addiction and Mental HealthCollaborator

Investigators

2
Eric L. Granholm, PhDPrincipal Investigator
Tarek Rajji, MD, FRCPCPrincipal Investigator

Sites

2 total
La Jolla, United StatesToronto, Canada

Facts & assertions

4 sourced
Enrollment
49
Phase
NA
Primary Completion Date
2026-02-10
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
E-CBSST
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
Centre for Addiction and Mental Health
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Eric L. Granholm, PhD
person
Tarek Rajji, MD, FRCPC
person